Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Solenostemon monostachyus, Ipomoea involucrata and Carica papaya seed oil versus Glutathione, or Vernonia amygdalina: methanolic extracts of novel plants for the management of sickle cell anemia disease.

Afolabi IS, Osikoya IO, Fajimi OD, Usoro PI, Ogunleye DO, Bisi-Adeniyi T, Adeyemi AO, Adekeye BT.

BMC Complement Altern Med. 2012 Dec 22;12:262. doi: 10.1186/1472-6882-12-262.

2.

Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia.

Imaga NA.

ScientificWorldJournal. 2013;2013:269659. doi: 10.1155/2013/269659. Epub 2013 Feb 14. Review.

3.

Recent insights on the medicinal chemistry of sickle cell disease.

Dos Santos JL, Chin CM.

Curr Med Chem. 2011;18(15):2339-58. doi: 0929-8673/11 $58.00+.00. Review.

PMID:
21517749
4.

Advances in sickle cell disease treatment: from drug discovery until the patient monitoring.

dos Santos JL, Lanaro C, Chin CM.

Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):113-27. Review.

PMID:
21401492
5.

Pharmaco-proteomic study of hydroxyurea-induced modifications in the sickle red blood cell membrane proteome.

Ghatpande SS, Choudhary PK, Quinn CT, Goodman SR.

Exp Biol Med (Maywood). 2008 Dec;233(12):1510-7. doi: 10.3181/0805-S-149. Epub 2008 Oct 10. Review.

6.

Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.

Okam MM, Ebert BL.

Expert Rev Hematol. 2012 Jun;5(3):303-11. doi: 10.1586/ehm.12.20. Review.

PMID:
22780210
7.

Phytomedicines (medicines derived from plants) for sickle cell disease.

Oniyangi O, Cohall DH.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004448. doi: 10.1002/14651858.CD004448.pub4. Review. Update in: Cochrane Database Syst Rev. 2015;(4):CD004448.

PMID:
23440792
8.

Phytomedicines (medicines derived from plants) for sickle cell disease.

Oniyangi O, Cohall DH.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD004448. doi: 10.1002/14651858.CD004448.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD004448.

PMID:
20927735
9.

Investigational agents for sickle cell disease.

Okpala I.

Expert Opin Investig Drugs. 2006 Aug;15(8):833-42. Review.

PMID:
16859388
10.

Established and experimental treatments for sickle cell disease.

De Franceschi L, Corrocher R.

Haematologica. 2004 Mar;89(3):348-56. Review.

11.

Sickle cell anemia and antisickling agents then and now.

Mehanna AS.

Curr Med Chem. 2001 Feb;8(2):79-88. Review.

PMID:
11172667
12.

Pathophysiologically based drug treatment of sickle cell disease.

Steinberg MH.

Trends Pharmacol Sci. 2006 Apr;27(4):204-10. Epub 2006 Mar 13. Review.

PMID:
16530854
13.

Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid.

Farombi EO, Owoeye O.

Int J Environ Res Public Health. 2011 Jun;8(6):2533-55. doi: 10.3390/ijerph8062533. Epub 2011 Jun 23. Review.

Supplemental Content

Support Center